PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Wheaton Precious Metals Corp. (WPM)
96.701.20 (1.26%)
95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.91%
Negative revenue growth while FSM stands at 104.72%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-5.35%
Negative gross profit growth while FSM is at 69.13%. Joel Greenblatt would examine cost competitiveness or demand decline.
-3.96%
Negative EBIT growth while FSM is at 114.19%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-3.96%
Negative operating income growth while FSM is at 114.19%. Joel Greenblatt would press for urgent turnaround measures.
-8.80%
Negative net income growth while FSM stands at 66.30%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-9.52%
Negative EPS growth while FSM is at 60.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-9.52%
Negative diluted EPS growth while FSM is at 60.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.02%
Share reduction more than 1.5x FSM's 0.34%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.03%
Diluted share count expanding well above FSM's 0.04%. Michael Burry would fear significant dilution to existing owners' stakes.
0.02%
Dividend growth of 0.02% while FSM is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-0.62%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-82.43%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
56.04%
10Y CAGR of 56.04% while FSM is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
176.47%
5Y CAGR of 176.47% while FSM is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
229.79%
3Y revenue/share CAGR at 50-75% of FSM's 366.92%. Martin Whitman would question if the firm lags behind competitor innovations.
12196.64%
10Y OCF/share CAGR above 1.5x FSM's 498.51%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
268.99%
OCF/share CAGR of 268.99% while FSM is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
426.39%
3Y OCF/share CAGR under 50% of FSM's 8686.67%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
10696.01%
Net income/share CAGR above 1.5x FSM's 970.52% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
273.92%
5Y net income/share CAGR at 75-90% of FSM's 333.15%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
367.76%
Below 50% of FSM's 2549.35%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
2022.77%
10Y equity/share CAGR above 1.5x FSM's 882.21%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
155.80%
5Y equity/share CAGR 1.25-1.5x FSM's 128.89%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
97.53%
3Y equity/share CAGR above 1.5x FSM's 49.98%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
39.73%
AR growth well above FSM's 23.42%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
-1.66%
Negative asset growth while FSM invests at 6.65%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.38%
50-75% of FSM's 4.61%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-7.69%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
0.94%
SG&A declining or stable vs. FSM's 20.07%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.